| LP172831-2 | No prenatal care | COMPONENT | 1 |
| LP172832-0 | Onset of labor | COMPONENT | 1 |
| LP172833-8 | Name of facility infant transferred to | COMPONENT | 1 |
| LP172834-6 | Histological placental examination was performed | COMPONENT | 1 |
| LP172835-3 | Autopsy was performed | COMPONENT | 2 |
| LP172836-1 | Infant living at time of report | COMPONENT | 1 |
| LP172837-9 | Infant was transferred within 24 hours of delivery | COMPONENT | 1 |
| LP172839-5 | Birth order | COMPONENT | 1 |
| LP17284-8 | Smooth Alder (Alnus rugosa) | COMPONENT | |
| LP172840-3 | Number of fetal deaths delivered | COMPONENT | 1 |
| LP172841-1 | Number of infants in this delivery delivered alive | COMPONENT | 1 |
| LP172845-2 | Steroid fractions interpretation | COMPONENT | 3 |
| LP172847-8 | Catecholamine metabolites and creatinine panel | COMPONENT | 1 |
| LP172849-4 | 6p25 and 6q23 and 11q and 8q24 and 9p21 chromosome partial aneuploidy | COMPONENT | 1 |
| LP17285-5 | White Alder (Alnus rhombifolia) | COMPONENT | |
| LP172850-2 | Risk factors in this pregnancy | COMPONENT | 1 |
| LP172851-0 | Mother was transferred for maternal medical or fetal indications for delivery | COMPONENT | 1 |
| LP172856-9 | Suspected chromosomal disorder karyotype status | COMPONENT | 1 |
| LP172857-7 | Down syndrome karyotype status | COMPONENT | 1 |
| LP172858-5 | Congenital anomalies of the newborn | COMPONENT | 1 |
| LP172859-3 | Maternal morbidity | COMPONENT | 1 |
| LP17286-3 | Alfalfa (Medicago sativa) | COMPONENT | |
| LP172860-1 | Nutrition | COMPONENT | 1 |
| LP172861-9 | Cardiopulmonary | CLASS | |
| LP172863-5 | Newborn age in hours | COMPONENT | 1 |
| LP172864-3 | Oxygen saturation sensor wrap type | COMPONENT | 1 |
| LP172865-0 | CCHD newborn screening panel | COMPONENT | 1 |
| LP172866-8 | Estimated timing of fetal death | COMPONENT | 1 |
| LP172867-6 | Abnormal conditions of the newborn | COMPONENT | 1 |
| LP172868-4 | Characteristics of labor and delivery | COMPONENT | 1 |
| LP172869-2 | Obstetric procedures performed | COMPONENT | 1 |
| LP172871-8 | Dosage of chromosome-specific cfDNA | METHOD | 68 |
| LP172873-4 | US Standard Certificate of Death | METHOD | 4 |
| LP172875-9 | Indexing - product concept | COMPONENT | 1 |
| LP172879-1 | pre dialysis - post dialysis | CHALLENGE | |
| LP17288-9 | Algae | COMPONENT | |
| LP172880-9 | unstimulated | DIVISORS | |
| LP172881-7 | Speech-language pathology+Audiology | METHOD | 2 |
| LP172883-3 | Adolescent depression screening assessment | COMPONENT | 1 |
| LP172884-1 | Adult depression screening assessment | COMPONENT | 1 |
| LP172887-4 | Speech-language pathology | METHOD | 27 |
| LP172888-2 | Coagulation factor VII | DIVISORS | |
| LP172889-0 | Bacteria.carbapenem resistant | COMPONENT | 2 |
| LP17289-7 | Allspice (Pimenta dioica) | COMPONENT | |
| LP172890-8 | Bacteria.extended spectrum beta lactamase resistance | COMPONENT | 1 |
| LP172891-6 | Bacteria.fluoroquinolone resistant | COMPONENT | 1 |
| LP172892-4 | Catecholamines 3 and creatinine panel | COMPONENT | 1 |
| LP172894-0 | Forensic medicine | Document.SubjectMatterDomain | 2 |
| LP172896-5 | Interventional radiology | Document.SubjectMatterDomain | 16 |
| LP172897-3 | Multidisciplinary | Document.SubjectMatterDomain | 1 |